We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

60 hedge funds and large institutions have $392M invested in Aerie Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

86% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 14

31% more capital invested

Capital invested by funds: $298M → $392M (+$93.9M)

13% more funds holding

Funds holding: 53 → 60 (+7)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
60
Holders Change
+7
Holders Change %
+13.21%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
15
Increased
26
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$15.8M
2
DM
Deerfield Management
New York
+$13.6M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.4M
4
Goldman Sachs
Goldman Sachs
New York
+$5.36M
5
CNB
City National Bank
California
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
IHM
Iguana Healthcare Management
New York
-$1.11M
2
ARC
Absolute Return Capital
Massachusetts
-$1.05M
3
IMS
Index Management Solutions
Pennsylvania
-$655K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$633K
5
Jennison Associates
Jennison Associates
New York
-$456K
Name Holding Trade Value Shares
Change 		Change in
Stake
RNS
51
Robert N. Shapiro
$22K – – –
VFA
52
Virtus Fund Advisers
Connecticut
$22K +$15.5K +896 New
Wells Fargo
53
Wells Fargo
California
$19K +$4.3K +248 +50%
BJ
54
BlackRock Japan
Japan
$13K -$8.97K -518 -49%
PNC Financial Services Group
55
PNC Financial Services Group
Pennsylvania
$12K +$8.66K +500 New
BlackRock
56
BlackRock
New York
$7K +$4.97K +287 New
Bank of Montreal
57
Bank of Montreal
Ontario, Canada
$5K +$3.46K +200 New
Barclays
58
Barclays
United Kingdom
$4K -$2.08K -120 -39%
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$3.69K +$2.36K +136 +1,046%
Citigroup
60
Citigroup
New York
$2K -$63.8K -3,685 -98%
ARC
61
Absolute Return Capital
Massachusetts
– -$1.05M -49,595 Closed
IMS
62
Index Management Solutions
Pennsylvania
– -$655K -30,892 Closed
CBOA
63
Commonwealth Bank of Australia
Australia
– -$233K -11,000 Closed
PP
64
PDT Partners
New York
– -$227K -10,734 Closed
SO
65
STRS Ohio
Ohio
– -$32K -1,500 Closed
GXMC
66
Global X Management Company
New York
– -$19K -909 Closed
U
67
UBS
Switzerland
– -$17K -768 Closed
Bank of America
68
Bank of America
North Carolina
– -$1K -37 Closed
1 2
3

AERI Hedge Fund Activity: Q2 2014 in Review

60 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q2 2014, worth a combined $392M — up 31% from $298M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AERI positions and 8 closed out — a net gain of 7 holders — while 26 added to existing stakes and 14 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $15.8M. The largest seller was Iguana Healthcare Management, cutting an estimated $1.11M.

  • 60 institutional investors held Aerie Pharmaceuticals (AERI) as of Q2 2014, up from 53 in Q1 2014.
  • Funds reported $392M of Aerie Pharmaceuticals stock for Q2 2014, up 31% quarter-over-quarter.
  • 15 funds opened new Aerie Pharmaceuticals positions in Q2 2014 and 8 closed out, a net change of +7 holders.
  • The largest Aerie Pharmaceuticals buyer in Q2 2014 was Perceptive Advisors, an estimated $15.8M added.
  • The largest Aerie Pharmaceuticals seller in Q2 2014 was Iguana Healthcare Management, an estimated $1.11M sold.

Based on aggregated 13F filings for Q2 2014.